BMT CTN Protocol 1205
Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials.
Below are protocol-related documents, which may be periodically updated.
- Protocol Synopsis, 5.0 dated July 27, 2016
- Protocol, 5.0 dated July 27, 2016
- Summary of Changes from version 4.0 to 5.0
- ETRIC 1101 v5.0 Informed consent
- ETRIC 1301 v3.0 Informed consent
- Participating Centers
- Frequently Asked Questions
- This study is posted on clinicaltrials.gov as NCT02081248
- Key Personnel
Protocol Co-Chair: Navneet S Majhail, MD (612-884-8676) majhain@ccf.org
Protocol Co-Chair: Ryan Spellecy, PhD (414-456-8763) rspellec@mcw.edu
Protocol Officer: Navneet S Majhail, MD (612-884-8676) majhain@ccf.org
Protocol Coordinator: Alyssa Ramirez (301-251-1161) aramirez@emmes.com
Medical Monitor: NA
The BMT CTN is committed to including widespread transplant community participation in these trials. However, due to the limited resources, not all requests can be accommodated for each protocol. If your center is interested in participating, please fax the completed Affiliate Center Application, or you may complete the short form if currently participating as an affiliate center in any other BMT CTN trial, and fax to BMT CTN DCC/Emmes at 240-306-0963.
